Adipokine concentrations in nonobese women: A study of reproductive aging, body mass index, and menstrual cycle effects

Biological Research for Nursing

Volumn 12, Issue 1, 2010, Pages 54-61

  Rouen, Patricia A ^a   Lukacs, Jane L ^b   Reame, Nancy E ^c  

^a UNIVERSITY OF DETROIT MERCY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Howard Hughes Medical Institute   (United States)

Author keywords

adipokines; menopause; menstrual cycle

Indexed keywords

ADIPOCYTOKINE;

ADULT; AGING; ARTICLE; BLOOD; BODY MASS; FEMALE; HUMAN; INSULIN RESISTANCE; MIDDLE AGED; REPRODUCTION;

ADIPOKINES; ADULT; AGING; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; REPRODUCTION;

EID: 77955590158     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800410365368     Document Type: Article

References (41)

1. Ahima, R.S. (2006). Metabolic actions of adipocyte hormones: Focus on adiponectin. Obesity, 14, 9S-15S.
2. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Madea, K., Miyagawa, J., & Matsuzawa, Y. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications, 257, 79-83.
3. Benetti-Pinto, C.L., Castro, N., Grassiotto, O., & Garmes, H.M. (2010). Leptin and adiponectin blood levels in women with premature ovarian failure and age- and weight-matched women with normal menstrual cycles. Menopause, 17, 174-177.
4. Carr, D.B., Utzschneider, K.M., Hull, R.L., Kodama, K., Retzlaff, B.M., Brunzell, J.D., & Kahn, S.E. (2004). Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome. Diabetes, 53, 2087-2094.
5. Carr, M.C. (2003). The emergence of the metabolic syndrome with menopause. Journal of Clinical Endocrinology and Metabolism, 88, 2404-2411.
6. Chu, M.C., Cosper, P., Orio, F., Carmina, E., & Lobo, R.A. (2006). Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. American Journal of Obstetrics & Gynecology, 194, 100-104.
7. Cnop, M.E., Havel, P.J., Utzschneider, K.M., Carr, D.B., Sinha, M.K., & Boyko, Kahn, S.E. (2003). Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologica, 46, 459-469.
8. Cnop, M.E., Landchild, M.J., Vidal, J., Havel, P., Knowles, N.G., Carr, D.R., & Kahn, S.E., (2002). The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes, 51, 1005-1015.
9. Dafopoulus, K., Sourlas, D., Kallitsaris, A., & Pournaras, S. & Messinis, I. (2009). Blood ghrelin, resistin, and adiponectin concentrations during the menstrual cycle. Fertility and Sterility, 92, 1389-1394.
10. Frystyk, J., Berne, C., Berglund, L., Jensevik, K., Flyvbjerg, A., & Zethelius, B. (2007). Serum adiponectin is a predictor of coronary heart disease: A population-based 10-year follow-up study in elderly men. Journal of Clinical Endocrinology and Metabolism, 92, 571-576.
11. Gavrila, A., Chan, J.L., Yiannakouris, N., Kontogianni, M., Miller, L.C., Orlova, C., & Mantzoros, C.S. (2003). Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: Cross-sectional and interventional studies. Journal of Clinical Endocrinology and Metabolism, 88, 4823-4831.
12. Guo, S.S., Zeller, C., Chumlea, W.C., & Siervogel, R.M. (1999). Aging, body composition, and lifestyle: The Fels longitudinal study. American Journal of Clinical Nutrition, 70, 405-411.
13. Hadji, P., Hars, O., Bock, K., Sturm, G., Bauer, T., Emons, G., & Schulz, K.D. (2000). The influence of menopause and body mass index on serum leptin concentrations. European Journal of Endocrinology, 143, 55-60.
14. Haffner, S.M., Mykkanen, L., & Stern, M.P. (1997). Leptin concentrations in women in the San Antonio Heart Study: Effect of menopausal status and postmenopausal hormone replacement therapy. American Journal of Epidemiology, 146, 581-585.
15. Hong, S.C., Yoo, S.W., Cho, G.J., Kim, T., Hur, J.Y., Park, Y.K., & Kim, S.H. (2007). Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women. Menopause, 14, 835-840.
16. Inoue, M., Yano, M., Yamakado, M., Maehata, E., & Suzuki, S. (2006). Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Metabolism: Clinical and Experimental, 55, 1248-1254.
17. Jurimae, J., Rembel, K., Jurimae, T., & Rehand, M. (2005). Adiponectin is associated with bone mineral density in perimenopausal women. Hormone and Metabolism Research, 37, 297-302.
18. Kannel, W.B., Cupples, L.A., Ramaswami, R., Stokes, J., III, Kreger, B.E., & Higgins, M. (1991). Regional obesity and risk of cardiovascular disease; the Framingham study. Journal of Clinical Epidemiology, 44, 183-190.
19. Kleiblova, P., Springer, D., & Haluzik, M. (2006). The influence of hormonal changes during the menstrual cycle on serum adiponectin concentrations in healthy women. Physiological Research, 55, 661-666.
20. Kontogianni, M.D., Dafni, U.G., Routsias, J.G., & Skopouli, F.N. (2004). Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. Journal of Bone and Mineral Research, 19, 546-551.
21. Lee, C.G., Carr, M.C., Murdoch, S.J., Mitchell, E., Woods, N.F., Wener, M.H., & Brunzell, J.D. (2009). Adipokines, inflammation, and visceral adiposity across the menopausal transition: A prospective study. Journal of Clinical Endocrinology and Metabolism, 94, 1104-1109.
22. Levy, J.C., Matthews, D.R., & Hermans, M.P. (1998). Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care, 21, 2191-2192.
23. Lukacs, J.L., Booth, S., Kleerekoper, M., Ansbacher, R., Rock, C.L., & Reame, N.E. (2006). Differential associations for menopause and age in measures of vitamin K, osteocalcin, and bone density: A cross-sectional exploratory study in healthy volunteers. Menopause, 13, 799-808.
24. Margetic, S., Cazzola, C., Pegg, G.G., & Hill, R.A. (2002). Leptin: A review of its peripheral actions and interactions. International Journal of Obesity, 26, 1407-1433.
25. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., & Treacher, D.F. & Turner, R.C. (1985). Homeostasis model assessment: Insulin resistance and beta cell function from fasting glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
26. Meier, U., & Gressner, A. (2004). Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clinical Chemistry, 50, 1511-1525.
27. Milewicz, A., Zatonska, K., Demissie, M., Jedrzejuk, D., Dunajska, K., Ilow, R., & Lwow, F. (2005). Serum adiponectin concentration and cardiovascular risk factors in climacteric women. Gynecological Endocrinology, 20, 68-73.
28. Miner, J.L. (2004). The adipocyte as an endocrine cell. Journal of Animal Science, 82, 935-942.
29. Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., & Matsuzawa, Y. (2002). Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes, 51, 2734-2741.
30. North American Menopause Society. (2007). Menopause practice: A clinician's guide (3rd ed.). Cleveland, OH: Author.
31. Park, Y.W., Zhuu, S., Palaniappan, L., Heshka, S., Carnethon, M.R., & Heymsfield, S.B. (2003). The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third National Health and Nutrition Examination Survey, 1988-1994. Archives of Internal Medicine, 163, 427-436.
32. Pedersen, S.B., Kristensen, K., Hermann, P., Katzenellenbogen, J.A., & Richelsen, B. (2004). Estrogen controls lipolysis by up-regulating α2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor α. Implications for the female fat distribution. Journal of Clinical Endocrinology and Metabolism, 89, 1869-1878.
33. Poehlman, E.T., Toth, M.J., & Gardner, A.W. (1995). Changes in energy balance and body composition at menopause: A controlled longitudinal study. Annals of Internal Medicine, 123, 673-675.
34. Reusch, J.E. (2002). Current concepts in insulin resistance, type 2 diabetes and the metabolic syndrome. American Journal of Cardiology, 90, 19G-26G.
35. Sieminska, L., Wojciechowska, C., Foltyn, W., Kajdaniuk, D., Kos-Kudla, B., Marek, B., & Zemczak, A. (2006). The relation of serum adiponectin and leptin levels to metabolic syndrome in women before and after menopause. Polish Journal of Endocrinology, 57, 16-22.
36. Soules, M.R., Sherman, S., Parrott, E., Rebar, R., Santoro, N., Utian, W., & Woods, N. (2001). Executive summary: Stages of reproductive aging workshop (STRAW). Fertility & Sterility, 76, 874-878.
37. Takemura, Y., Osuga, Y., Harada, M., Hirata, T., Koga, K., Morimoto, C., & Taketani, Y. (2005). Serum adiponectin concentrations are decreased in women with endometriosis. Human Reproduction, 20, 3510-3513.
38. Trujillo, M.E., & Scherer, P.E. (2005). Adiponectin-Journey from an adipocyte secretory protein to a biomarker of the metabolic syndrome. Journal of Internal Medicine 257, 167-175.
39. van Harmelen, V., Reynisdottir, S., Eriksson, P., Thorne, A., Hoffstedt, J., Lonnqvist, F., & Arner, P. (1998). Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes, 47, 913-917.
40. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E., & Tataranni, P.A. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism, 86, 1930-1935.
41. Zoico, E., DiFrancesco, V., Mazzali, G., Vettor, R., Fantin, F., Bissoli, L., & Zamboni, M. (2004). Adipocytokines, fat distribution and insulin resistance in elderly men and women. Journals of Gerontology, 59A, 935-938.